Search Results

QP35-26 Intensive Residential Treatment Services (IRTS) Prior Authorization (PA) Requirements

QP34-26 Billing Changes for Opioid Treatment Programs for Minnesota Health Care Programs

Compounded Medications - Commercial

Formulary Exception, Coverage Exception

Non-Preferred Drug with Continuation of Therapy - Medicaid

Prior Authorization

Pulmonary Arterial Hypertension - Commercial

Prior Authorization, Quantity Limit

Galafold (migalastat) - Commercial

Prior Authorization, Quantity Limit

Erythropoietins - Commercial

Prior Authorization

Leucovorin - Commercial

Prior Authorization, Quantity Limit

Substrate Reduction Therapy - Commercial

Prior Authorization, Quantity Limit

Cablivi (caplacixumab-yhdp) - Commercial

Prior Authorization, Quantity Limit